Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high…
Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
MLMs Need to be Included in FTC’s Business Opportunity Rule
TINA.org files comment in support of applying rule to direct selling industry.
Call Me with Timothée Chalamet | Apple TV+
Even celebs have FOMO
Medical Mike’s CBD Oils
Don’t Be Like Mike and get an FDA/FTC warning letter regarding COVID claims.
Step2’s Made in USA Claims
U.S.-origin claims questioned after consumer receives box labeled ‘Made in Vietnam.’
Consumer advocacy groups want Walmart’s Roblox game audited for ‘stealth marketing’ to kids
Sarah Perez, TechCrunch